|
OSBPL8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.442190E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.849950E-02 |
| Normal-vs-Stage2 |
2.335600E-02 |
| Normal-vs-Stage3 |
6.762300E-02 |
| Normal-vs-Stage4 |
8.341300E-03 |
| Stage1-vs-Stage2 |
5.922800E-01 |
| Stage1-vs-Stage3 |
6.832800E-01 |
| Stage1-vs-Stage4 |
4.407800E-01 |
| Stage2-vs-Stage3 |
4.825200E-01 |
| Stage2-vs-Stage4 |
8.681400E-01 |
| Stage3-vs-Stage4 |
3.577600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.383700E-02 |
| Normal-vs-AfricanAmerican |
1.020590E-01 |
| Normal-vs-Asian |
5.481200E-03 |
| Caucasian-vs-AfricanAmerican |
8.235200E-01 |
| Caucasian-vs-Asian |
2.252200E-01 |
| AfricanAmerican-vs-Asian |
4.861000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.957400E-03 |
| Normal-vs-Female |
2.569600E-02 |
| Male-vs-Female |
4.083400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.081960E-01 |
| Normal-vs-Age(41-60Yrs) |
2.760500E-03 |
| Normal-vs-Age(61-80Yrs) |
2.748200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.664000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.060750E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.487600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.470000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.296800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.340800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.836800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.079800E-01 |
| Classical-VS-Follicular |
4.00230000000557E-05 |
| Classical-VS-Other |
1.319620E-01 |
| Classical-VS-Normal |
1.261770E-01 |
| Tall-VS-Follicular |
8.637500E-03 |
| Tall-VS-Other |
1.340370E-01 |
| Tall-VS-Normal |
7.671200E-01 |
| Follicular-VS-Other |
8.661400E-01 |
| Follicular-VS-Normal |
1.57924999999448E-05 |
| Other-VS-Normal |
2.903900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.624300E-04 |
| Normal-vs-N1 |
1.691550E-02 |
| N0-vs-N1 |
6.087000E-01 |
|
|
